acalabrutinib
astrazeneca
['acalabrutinib', 'cll', 'leusm']
long-term follow-up supports acalabrutinib-based regimens in treatment-na ve cll #asco22 #leusm #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.